Home testing for COVID-19: lessons from direct to consumer genetics

Area of Science:

• Public Health
• Genetics
• Regulatory Science

Background:

• The COVID-19 pandemic, declared March 11th, 2020, highlighted significant gaps in publicly available testing.
• Technological entrepreneurs have emerged to address these testing deficiencies.
• Direct-to-consumer (DTC) genetic testing, bypassing traditional clinical channels, has been available for two decades.

Purpose of the Study:

• To examine lessons learned from the established DTC genetic testing market.
• To inform regulatory approaches for emerging DTC COVID-19 testing.

Main Methods:

• Commentary and analysis of historical trends in DTC genetic testing.
• Comparative assessment of regulatory considerations for genetic versus infectious disease testing.

Main Results:

• The DTC genetic testing model provides a precedent for rapid consumer access to health information.
• Potential risks and regulatory challenges observed in DTC genetic testing may be relevant to DTC COVID-19 testing.

Conclusions:

• Regulatory frameworks must carefully consider the implications of DTC COVID-19 testing.
• A cautious approach, informed by the DTC genetic testing experience, is recommended to ensure accuracy, safety, and ethical oversight.